Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population

Infection, Genetics and Evolution

Volumn 9, Issue 5, 2009, Pages 877-881

  Ezzikouri, Sayeh ^a   El feydi, Abdellah Essaid ^b   Benazzouz, Mustapha ^b   Afifi, Rajae ^b   El kihal, Latifa ^b   Hassar, Mohammed ^a   Akil, Abdellah ^a   Pineau, Pascal ^c   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

^c INSTITUT PASTEUR   (France)

Author keywords

DNA methyltransferase 3B; Hepatocellular carcinoma; Polymorphism

Indexed keywords

DNA METHYLTRANSFERASE 3B;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOROCCO; NUCLEOTIDE SEQUENCE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOROCCO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

HEPATITIS C VIRUS;

EID: 67651119885     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.05.012     Document Type: Article

References (38)

1. Arora P., Kim E.O., Jung J.K., and Jang K.L. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett. 261 (2008) 244-252
2. Beaulieu N., Morin S., Chute I.C., Robert M.F., Nguyen H., and MacLeod A.R. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J. Biol. Chem. 277 (2002) 28176-28181
3. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9 (2000) 2395-2402
4. Cebrian A., Pharoah P.D., Ahmed S., Ropero S., Fraga M.F., Smith P.L., Conroy D., Luben R., Perkins B., Easton D.F., Dunning A.M., Esteller M., and Ponder B.A. Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 27 (2006) 1661-1669
5. Eng C., Herman J.G., and Baylin S.B. A bird's eye view of global methylation. Nat. Genet. 24 (2000) 101-102
6. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 358 (2008) 1148-1159
7. Ezzikouri S., El Feydi A.E., Afifi R., El Kihal L., Benazzouz M., Hassar M., Marchio A., Pineau P., and Benjelloun S. MDM2 SNP309T > G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population. Cancer Detect. Prev. (2009)
8. Ezzikouri S., El Feydi A.E., Chafik A., Afifi R., El Kihal L., Benazzouz M., Hassar M., Pineau P., and Benjelloun S. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. Mutat. Res. 649 (2008) 1-6
9. Ezzikouri S., El Feydi A.E., Chafik A., Benazzouz M., El Kihal L., Afifi R., Hassar M., Pineau P., and Benjelloun S. The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol. Res. 37 (2007) 748-754
10. Ezzikouri S., El Feydi A.E., El Kihal L., Afifi R., Benazzouz M., Hassar M., Chafik A., Pineau P., and Benjelloun S. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population. Arch. Med. Res. 39 (2008) 236-241
11. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 6 (2006) 674-687
12. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 4 (2004) 143-153
13. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
14. Hecker K.H., and Roux K.H. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques 20 (1996) 478-485
15. Jinawath A., Miyake S., Yanagisawa Y., Akiyama Y., and Yuasa Y. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem. J. 385 (2005) 557-564
16. Jones J.S., Amos C.I., Pande M., Gu X., Chen J., Campos I.M., Wei Q., Rodriguez-Bigas M., Lynch P.M., and Frazier M.L. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 886-891
17. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
18. Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Grieu F., Watanabe G., and Iacopetta B. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer 94 (2006) 593-598
19. Klose R.J., and Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31 (2006) 89-97
20. Lee S., Lee H.J., Kim J.H., Lee H.S., Jang J.J., and Kang G.H. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol. 163 (2003) 1371-1378
21. Lehmann U., Wingen L.U., Brakensiek K., Wedemeyer H., Becker T., Heim A., Metzig K., Hasemeier B., Kreipe H., and Flemming P. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Hum. Mol. Genet. 16 (2007) 1335-1342
22. Liu K., Wang Y.F., Cantemir C., and Muller M.T. Endogenous assays of DNA methyltransferases: evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Mol. Cell. Biol. 23 (2003) 2709-2719
23. McKillop I.H., Moran D.M., Jin X., and Koniaris L.G. Molecular pathogenesis of hepatocellular carcinoma. J. Surg. Res. (2006)
24. Momparler R.L., and Bovenzi V. DNA methylation and cancer. J. Cell. Physiol. 183 (2000) 145-154
25. Montgomery K.G., Liu M.C., Eccles D.M., and Campbell I.G. The DNMT3B C → T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res. 6 (2004) R390-R394
26. Moradpour D., and Blum H.E. Pathogenesis of hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 17 (2005) 477-483
27. Nishida N., Nagasaka T., Nishimura T., Ikai I., Boland C.R., and Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 47 (2008) 908-918
28. Pineau P., Ezzikouri S., Marchio A., Benazzouz M., Cordina E., Afifi R., Elkihal L., Khalfallah M.T., Mestiri H., Tebbal S., Berkane S., Debzi N., Triki H., Dejean A., Iguer F., Bahri O., Essaid El Feydi A.E., and Benjelloun S. Genomic stability prevails in North-African hepatocellular carcinomas. Dig. Liver Dis. 39 (2007) 671-677
29. Raiche J., Rodriguez-Juarez R., Pogribny I., and Kovalchuk O. Sex- and tissue-specific expression of maintenance and de novo DNA methyltransferases upon low dose X-irradiation in mice. Biochem. Biophys. Res. Commun. 325 (2004) 39-47
30. Robertson K.D., and Wolffe A.P. DNA methylation in health and disease. Nat. Rev. Genet. 1 (2000) 11-19
31. Shen H., Wang L., Spitz M.R., Hong W.K., Mao L., and Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 62 (2002) 4992-4995
32. Shen L., Fang J., Qiu D., Zhang T., Yang J., Chen S., and Xiao S. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma. Hepatogastroenterology 45 (1998) 1753-1759
33. Simao Tde A., Simoes G.L., Ribeiro F.S., Cidade D.A., Andreollo N.A., Lopes L.R., Macedo J.M., Acatauassu R., Teixeira A.M., Felzenszwalb I., Pinto L.F., and Albano R.M. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas. Hum. Exp. Toxicol. 25 (2006) 515-522
34. Tsai C.L., Li H.P., Lu Y.J., Hsueh C., Liang Y., Chen C.L., Tsao S.W., Tse K.P., Yu J.S., and Chang Y.S. Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH(2)-terminal kinase signaling. Cancer Res. 66 (2006) 11668-11676
35. Wang L., Rodriguez M., Kim E.S., Xu Y., Bekele N., El-Naggar A.K., Hong W.K., Mao L., and Oh Y.W. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int. J. Oncol. 25 (2004) 993-999
36. Wang Y.M., Wang R., Wen D.G., Li Y., Guo W., Wang N., Wei L.Z., He Y.T., Chen Z.F., Zhang X.F., and Zhang J.H. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. World J. Gastroenterol. 11 (2005) 3623-3627
37. Wu Y., and Lin J.S. DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study. World J. Gastroenterol. 13 (2007) 6082-6086
38. Xiao Y., Word B., Starlard-Davenport A., Haefele A., Lyn-Cook B.D., and Hammons G. Age and gender affect DNMT3a and DNMT3b expression in human liver. Cell Biol. Toxicol. 24 (2008) 265-272